Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

A millimeter miss is as good as a thousand miles: The role of accurate target localization in lung stereotactic body radiation therapy.

Chen AY, Chen MB, Chen YJ.

J Thorac Dis. 2012 Apr 1;4(2):109-11. doi: 10.3978/j.issn.2072-1439.2012.03.12. No abstract available.

2.

Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.

Crabtree TD, Denlinger CE, Meyers BF, El Naqa I, Zoole J, Krupnick AS, Kreisel D, Patterson GA, Bradley JD.

J Thorac Cardiovasc Surg. 2010 Aug;140(2):377-86. doi: 10.1016/j.jtcvs.2009.12.054. Epub 2010 Apr 18.

3.

Stereotactic body radiation therapy for lung cancer: achievements and perspectives.

Hiraoka M, Matsuo Y, Takayama K.

Jpn J Clin Oncol. 2010 Sep;40(9):846-54. doi: 10.1093/jjco/hyq134. Epub 2010 Jul 29.

PMID:
20670962
4.

Stereotactic body radiotherapy for second pulmonary nodules after operation for an initial lung cancer.

Nishiyama K, Kodama K, Teshima T, Tada H.

Jpn J Clin Oncol. 2015 Oct;45(10):947-52. doi: 10.1093/jjco/hyv113. Epub 2015 Aug 3.

PMID:
26238818
5.

Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).

Dunlap NE, Larner JM, Read PW, Kozower BD, Lau CL, Sheng K, Jones DR.

J Thorac Cardiovasc Surg. 2010 Sep;140(3):583-9. doi: 10.1016/j.jtcvs.2010.01.046. Epub 2010 May 15.

6.

Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: localization, verification, and intrafraction tumor position.

Purdie TG, Bissonnette JP, Franks K, Bezjak A, Payne D, Sie F, Sharpe MB, Jaffray DA.

Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):243-52. Epub 2007 Feb 27.

PMID:
17331671
7.

Benefit of three-dimensional image-guided stereotactic localization in the hypofractionated treatment of lung cancer.

Wang L, Feigenberg S, Chen L, Pasklev K, Ma CC.

Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):738-47. Epub 2006 Sep 1.

PMID:
16949768
8.

A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.

Puri V, Crabtree TD, Kymes S, Gregory M, Bell J, Bradley JD, Robinson C, Patterson GA, Kreisel D, Krupnick AS, Meyers BF.

J Thorac Cardiovasc Surg. 2012 Feb;143(2):428-36. doi: 10.1016/j.jtcvs.2011.10.078. Epub 2011 Dec 9.

9.

Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT).

Folkert MR, Timmerman RD.

Adv Drug Deliv Rev. 2017 Jan 15;109:3-14. doi: 10.1016/j.addr.2016.11.005. Epub 2016 Dec 5. Review.

PMID:
27932046
10.

Repositioning accuracy of a commercially available double-vacuum whole body immobilization system for stereotactic body radiation therapy.

Fuss M, Salter BJ, Rassiah P, Cheek D, Cavanaugh SX, Herman TS.

Technol Cancer Res Treat. 2004 Feb;3(1):59-67.

PMID:
14750894
11.

Stereotactic body radiation therapy for oligometastases.

Lo SS, Teh BS, Mayr NA, Olencki TE, Wang JZ, Grecula JC, Lu JJ, Timmerman RD.

Discov Med. 2010 Sep;10(52):247-54.

12.

[Stereotactic radiotherapy for stage I and II lung cancer: a study of 33 patients].

Champeaux-Orange E, Wachter T, Bouscayrol H, Barillot I.

Cancer Radiother. 2011 Jun;15(3):192-6. doi: 10.1016/j.canrad.2010.10.002. Epub 2011 Feb 16. French.

PMID:
21330178
13.

Three-fraction stereotactic body radiation therapy for isolated liver recurrence from colorectal cancer.

Kim MS, Kang JK, Cho CK, Choi CW, Seo YS, Hwang DY, Moon SM, Kang HJ, Kim YH, Kim MS, Oh N.

Tumori. 2009 Jul-Aug;95(4):449-54.

14.

Helical tomotherapy-based STAT stereotactic body radiation therapy: Dosimetric evaluation for a real-time SBRT treatment planning and delivery program.

Dunlap N, McIntosh A, Sheng K, Yang W, Turner B, Shoushtari A, Sheehan J, Jones DR, Lu W, Ruchala K, Olivera G, Parnell D, Larner JL, Benedict SH, Read PW.

Med Dosim. 2010 Winter;35(4):312-9. doi: 10.1016/j.meddos.2010.08.002.

PMID:
21055611
15.

Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer.

Tramontano AC, Cipriano LE, Kong CY, Shepard JA, Lanuti M, Gazelle GS, McMahon PM.

AJR Am J Roentgenol. 2013 May;200(5):1020-7. doi: 10.2214/AJR.12.8968.

16.

Stereotactic body radiation therapy for early-stage non-small-cell lung cancer.

Lo SS, Fakiris AJ, Papiez L, Abdulrahman R, McGarry RC, Henderson MA, Forquer JA, Hoopes D, Timmerman RD.

Expert Rev Anticancer Ther. 2008 Jan;8(1):87-98. Review. Erratum in: Expert Rev Anticancer Ther. 2010 Jan;10(1):120. Expert Rev Anticancer Ther. 2009 Sep;9(9):1347.

PMID:
18095886
17.

Factors influencing intrafractional target shifts in lung stereotactic body radiation therapy.

Liu HW, Khan R, Nugent Z, Krobutschek K, Dunscombe P, Lau H.

Pract Radiat Oncol. 2014 Jan-Feb;4(1):e45-51. doi: 10.1016/j.prro.2013.02.013. Epub 2013 Apr 9.

PMID:
24621431
19.

Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer.

Abbas G, Danish A, Krasna MJ.

Surg Oncol Clin N Am. 2016 Jul;25(3):553-66. doi: 10.1016/j.soc.2016.02.008. Review.

PMID:
27261915
20.

[Lung cancer: Stereotactic body radiation therapy and surgery].

Antoni D, Srour I, Mornex F.

Cancer Radiother. 2015 Oct;19(6-7):371-6. doi: 10.1016/j.canrad.2015.06.014. Epub 2015 Sep 7. French.

PMID:
26358983

Supplemental Content

Support Center